GD Stride

Dynamic Platform for treating diabetic feet

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in September 2019 by Daniel Aharon Weisz and Gidon Weinberger, GD Stride operates with 1-10 employees. The company completed its graduation from the Hadassah Accelerator program in March 2023, signaling its progress in developing innovative health technology solutions.

Business overview

GD Stride develops a dynamic platform focused on preventing amputations in diabetic feet. The company's core technology integrates biomechanical data into a system that adapts to provide optimal interaction between posture, anatomy, and foot dynamics. This enables personalized solutions for a pain-free, balanced, and healthy walk. GD Stride's advanced technology offers accurate diagnosis and remote implementation within the platform to adjust posture and heal serious wounds, serving the digital healthcare, digital therapeutics, and medical devices sectors.

Log in to access full profile

Company Intelligence Q&A

What is GD Stride's primary focus?
GD Stride's primary focus is developing a dynamic platform designed to prevent amputations of diabetic feet by optimizing posture, anatomy, and foot dynamics.
When was GD Stride founded?
GD Stride was founded in September 2019.
Who are the founders of GD Stride?
GD Stride was founded by Daniel Aharon Weisz and Gidon Weinberger.
Which accelerator program did GD Stride graduate from in 2023?
GD Stride graduated from the Hadassah Accelerator program in March 2023.
What is GD Stride's product stage?
GD Stride's product is currently in the R&D stage, as confirmed by their company profile.
Log in to access full profile